MMJD OTCQB: The firm changed direction and signed a North American licensing agreement with Phoenix Bio Pharmaceuticals Corporation on March 14, 2014. The license includes: "transdermal patches, orally administered extracts, concentrated extracts for vaporisers and inhalers, sublingual and buccal dispensing products and extraction technology, suppository delivery systems, salves, creams, gels, lotions, and liquid extracts, and any products or active ingredients sources through Phoenix Bio Pharm affiliates or third party suppliers or licensors."
Medijane Holdings, Inc. was formerly named Mokita, Inc. dedicated to oil and gas development. 8-K: 'On February 28, 2014, we received written consent from our company’s board of directors and the holders of 51.47% of our company’s voting securities to change the name of our company to MediJane Holdings Inc.'
Under SEC Reg D MMJD, issued 26,000,000 million shares to acquire the license. This transaction was announced in March 14, 2014 via 8-K. See note below explaining Regulation D.
OTCM Co. Info
Shares Outstanding 63,000,000 a/o Jan 15, 2014
Authorized Shares 100,000,000 a/o Mar 20, 2014
From an 8K: : '...on February 27, 2014, we appointed Ronald Lusk as president, chief executive officer and director of our company. In consideration of Mr. Lusk acting as an officer our company, we agreed to issue 5,000,000 shares of our common stock to Mr. Lusk. The shares were issued pursuant to an exemption from registration requirements under Rule 506 of Regulation D of the Securities Act of 1933.'
This Reg D 5m plus recent Reg D 26m for license acquistion indicates the current O/S would be at least 63 + 26 + 5 = 94million shares.
If there are 94m shs, the market cap would be $81.78m based on $0.87 PPS. Pricey given that on 02/28/2014 Lusk purchased 30,000,000 common shares of MMJD in a private transaction for only $2,000, or $0.000067 per share.
From an 8-K: "On February 28, 2014, Caduceus Industries Ltd. (“Caduceus”) acquired 30,000,000 shares of our company’s common stock from Irma Colon-Alonso, a former officer and director of our company, pursuant to the terms of a Stock Purchase Agreement dated February 28, 2014 for total consideration of $2,000. The funds used for the share purchase were from Caduceus’ private funds. Following the acquisition, Caduceus owns 44.118% of the issued and outstanding stock of our company. Mr. Ronald Lusk has voting and dispositive control over securities held by Caduceus Industries Ltd."
Note:
Regulation D
"A Securities and Exchange Commission (SEC) regulation governing private placement exemptions. Reg D offerings are advantageous to any private company or entrepreneur because they allow an entity to obtain funding faster and to avoid the costs associated with a public offering. Even if the transaction only involves one or two investors, the company or entrepreneur wanting to raise capital still needs to provide the proper framework and disclosure documentation; however, these requirements are significantly less than what is required for a public offering."
ps. About that other ticker, tread with caution. Lack of outgoing PM function restricts what I can say here. Products good, but that's not where the issues of timely consequence rest. Did you ever build a structure using playing cards?
Medijane Holdings, Inc. was formerly named Mokita, Inc. dedicated to oil and gas development. 8-K: 'On February 28, 2014, we received written consent from our company’s board of directors and the holders of 51.47% of our company’s voting securities to change the name of our company to MediJane Holdings Inc.'
Under SEC Reg D MMJD, issued 26,000,000 million shares to acquire the license. This transaction was announced in March 14, 2014 via 8-K. See note below explaining Regulation D.
OTCM Co. Info
Shares Outstanding 63,000,000 a/o Jan 15, 2014
Authorized Shares 100,000,000 a/o Mar 20, 2014
From an 8K: : '...on February 27, 2014, we appointed Ronald Lusk as president, chief executive officer and director of our company. In consideration of Mr. Lusk acting as an officer our company, we agreed to issue 5,000,000 shares of our common stock to Mr. Lusk. The shares were issued pursuant to an exemption from registration requirements under Rule 506 of Regulation D of the Securities Act of 1933.'
This Reg D 5m plus recent Reg D 26m for license acquistion indicates the current O/S would be at least 63 + 26 + 5 = 94million shares.
If there are 94m shs, the market cap would be $81.78m based on $0.87 PPS. Pricey given that on 02/28/2014 Lusk purchased 30,000,000 common shares of MMJD in a private transaction for only $2,000, or $0.000067 per share.
From an 8-K: "On February 28, 2014, Caduceus Industries Ltd. (“Caduceus”) acquired 30,000,000 shares of our company’s common stock from Irma Colon-Alonso, a former officer and director of our company, pursuant to the terms of a Stock Purchase Agreement dated February 28, 2014 for total consideration of $2,000. The funds used for the share purchase were from Caduceus’ private funds. Following the acquisition, Caduceus owns 44.118% of the issued and outstanding stock of our company. Mr. Ronald Lusk has voting and dispositive control over securities held by Caduceus Industries Ltd."
Note:
Regulation D
"A Securities and Exchange Commission (SEC) regulation governing private placement exemptions. Reg D offerings are advantageous to any private company or entrepreneur because they allow an entity to obtain funding faster and to avoid the costs associated with a public offering. Even if the transaction only involves one or two investors, the company or entrepreneur wanting to raise capital still needs to provide the proper framework and disclosure documentation; however, these requirements are significantly less than what is required for a public offering."
ps. About that other ticker, tread with caution. Lack of outgoing PM function restricts what I can say here. Products good, but that's not where the issues of timely consequence rest. Did you ever build a structure using playing cards?
